Literature DB >> 21749853

No increased risk of myocardial infarction among patients with ulcerative colitis or Crohn's disease.

Mark T Osterman1, Yu-Xiao Yang, Colleen Brensinger, Kimberly A Forde, Gary R Lichtenstein, James D Lewis.   

Abstract

BACKGROUND & AIMS: Patients with chronic inflammatory diseases such as rheumatoid arthritis, systemic lupus erythematosus, and psoriasis have an increased risk of myocardial infarction (MI). Studies of the risk of MI among patients with inflammatory bowel disease have provided inconsistent results. We aimed to determine the risk of first-time acute MI in patients with ulcerative colitis (UC) or Crohn's disease (CD) compared with patients from general practice.
METHODS: We conducted 2 retrospective cohort studies using the General Practice Research Database. A total of 15,498 UC patients were matched to 144,605 general practice patients (for age, sex, year of enrollment in the General Practice Research Database, and general practice of attendance) and were followed up for a mean of 4.7 years; 9829 CD patients were matched to 92,987 patients from general practice and followed up for a mean of 4.5 years. Univariable and multivariable Cox regression analyses were adjusted for age, sex, history of hypertension, diabetes mellitus, hypercholesterolemia, smoking status, body mass index, and aspirin use for each cohort.
RESULTS: Patients with UC had a significantly increased risk of first-time acute MI compared with patients from general practice in unadjusted, but not adjusted, analysis (adjusted hazard ratio, 1.11; 95% confidence interval, 0.98-1.27). Patients with CD did not have an increased risk of MI in either unadjusted or adjusted analyses (adjusted hazard ratio, 1.09; 95% confidence interval, 0.89-1.34).
CONCLUSIONS: Unlike some other chronic inflammatory diseases, inflammatory bowel disease is not associated with an increased risk of MI.
Copyright © 2011 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21749853      PMCID: PMC3183342          DOI: 10.1016/j.cgh.2011.06.032

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  39 in total

Review 1.  Inflammation, atherosclerosis, and coronary artery disease.

Authors:  Göran K Hansson
Journal:  N Engl J Med       Date:  2005-04-21       Impact factor: 91.245

2.  Antirheumatic drug use and the risk of acute myocardial infarction.

Authors:  Samy Suissa; Sasha Bernatsky; Marie Hudson
Journal:  Arthritis Rheum       Date:  2006-08-15

3.  Acute respiratory-tract infections and risk of first-time acute myocardial infarction.

Authors:  C R Meier; S S Jick; L E Derby; C Vasilakis; H Jick
Journal:  Lancet       Date:  1998-05-16       Impact factor: 79.321

4.  Risk of myocardial infarction in patients with psoriasis.

Authors:  Joel M Gelfand; Andrea L Neimann; Daniel B Shin; Xingmei Wang; David J Margolis; Andrea B Troxel
Journal:  JAMA       Date:  2006-10-11       Impact factor: 56.272

5.  Immunosuppressive medications and hospitalization for cardiovascular events in patients with rheumatoid arthritis.

Authors:  Daniel H Solomon; Jerry Avorn; Jeffrey N Katz; Michael E Weinblatt; Soko Setoguchi; Raisa Levin; Sebastian Schneeweiss
Journal:  Arthritis Rheum       Date:  2006-12

Review 6.  Inflammation and coagulation in inflammatory bowel disease: The clot thickens.

Authors:  Silvio Danese; Alfredo Papa; Simone Saibeni; Alessandro Repici; Alberto Malesci; Maurizio Vecchi
Journal:  Am J Gastroenterol       Date:  2006-11-13       Impact factor: 10.864

7.  The relationship between time since registration and measured incidence rates in the General Practice Research Database.

Authors:  James D Lewis; Warren B Bilker; Rachel B Weinstein; Brian L Strom
Journal:  Pharmacoepidemiol Drug Saf       Date:  2005-07       Impact factor: 2.890

8.  Glucocorticoids and cardiovascular events in rheumatoid arthritis: a population-based cohort study.

Authors:  John M Davis; Hilal Maradit Kremers; Cynthia S Crowson; Paulo J Nicola; Karla V Ballman; Terry M Therneau; Véronique L Roger; Sherine E Gabriel
Journal:  Arthritis Rheum       Date:  2007-03

9.  General and cancer specific mortality of a population based cohort of patients with inflammatory bowel disease: the Florence Study.

Authors:  D Palli; G Trallori; C Saieva; O Tarantino; E Edili; G D'Albasio; F Pacini; G Masala
Journal:  Gut       Date:  1998-02       Impact factor: 23.059

10.  Premature morbidity from cardiovascular and cerebrovascular diseases in women with systemic lupus erythematosus.

Authors:  M M Ward
Journal:  Arthritis Rheum       Date:  1999-02
View more
  28 in total

1.  Increased Risk of Acute Myocardial Infarction and Heart Failure in Patients With Inflammatory Bowel Diseases.

Authors:  Satimai Aniwan; Darrell S Pardi; William J Tremaine; Edward V Loftus
Journal:  Clin Gastroenterol Hepatol       Date:  2018-04-24       Impact factor: 11.382

Review 2.  Cardiovascular complications in inflammatory bowel disease.

Authors:  Rudolf Schicho; Gunther Marsche; Martin Storr
Journal:  Curr Drug Targets       Date:  2015       Impact factor: 3.465

3.  Persistent Reactive Thrombocytosis May Increase the Risk of Coronary Artery Disease Among Inflammatory Bowel Disease Patients.

Authors:  Sudeep Dhoj Thapa; Hiba Hadid; Waseem Imam; Ahmad Hassan; Muhammad Usman; Syed-Mohammed Jafri; Jason Schairer
Journal:  Dig Dis Sci       Date:  2015-05-14       Impact factor: 3.199

Review 4.  Role of Inflammatory Diseases in Hypertension.

Authors:  E Bartoloni; A Alunno; V Valentini; F Luccioli; E Valentini; G La Paglia; O Bistoni; Roberto Gerli
Journal:  High Blood Press Cardiovasc Prev       Date:  2017-06-09

Review 5.  Epidemiology, risk factors and management of cardiovascular diseases in IBD.

Authors:  Siddharth Singh; Iftikhar J Kullo; Darrell S Pardi; Edward V Loftus
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2014-12-02       Impact factor: 46.802

6.  Steroid exposure, acute coronary syndrome, and inflammatory bowel disease: insights into the inflammatory milieu.

Authors:  Pearl Zakroysky; Wai-Ee Thai; Roderick C Deaño; Sandeep Basnet; Zurine Galvan Onandia; Sachin Gandhi; Ahmed Tawakol; James K Min; Quynh A Truong
Journal:  Am J Med       Date:  2014-11-13       Impact factor: 4.965

Review 7.  Unmet Needs in the Pathogenesis and Treatment of Cardiovascular Comorbidities in Chronic Inflammatory Diseases.

Authors:  Cristina Panico; Gianluigi Condorelli
Journal:  Clin Rev Allergy Immunol       Date:  2018-12       Impact factor: 8.667

Review 8.  Cardiovascular involvement in inflammatory bowel disease: Dangerous liaisons.

Authors:  Ana Maria Filimon; Lucian Negreanu; Michelle Doca; Andreea Ciobanu; Carmen Monica Preda; Dragos Vinereanu
Journal:  World J Gastroenterol       Date:  2015-09-07       Impact factor: 5.742

9.  Hospitalizations for Acute Myocardial Infarction Are Decreased Among Patients with Inflammatory Bowel Disease Using a Nationwide Inpatient Database.

Authors:  Edward L Barnes; Renee M Beery; Allison R Schulman; Ellen P McCarthy; Joshua R Korzenik; Rachel W Winter
Journal:  Inflamm Bowel Dis       Date:  2016-09       Impact factor: 5.325

10.  Eosinophilia and Ulcerative Colitis Associated with Eosinophilic Myocarditis.

Authors:  Katie Murphy; Oral Waldo; Graham M Lohrmann; Henry D Tazelaar; Clinton E Jokerst; Farouk Mookadam
Journal:  Tex Heart Inst J       Date:  2017-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.